Â鶹´«Ã½Ó³»­

Â鶹´«Ã½Ó³»­

Explore the latest content from across our publications
Join The Â鶹´«Ã½Ó³»­

Log In

Forgot Password?
Create New Account

Loading... please wait

2023 Annual Meeting | C24 - Pediatric Headache

Saturday 04/22/23
02:45 PM - 04:45 PM EST Add To Calendar
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Seminar
Kenneth J. Mack, MD, PhD, FÂ鶹´«Ã½Ó³»­
Child Neurology and Developmental Neurology, Headache
Participants should be able to apply a holistic approach to the treatment of children and adolescents with migraine that ranges from lifestyle factors, to appropriate acute therapies, to prevention; appraise recent studies of injection and neurostimulation therapies in child and adolescent migraine; and recognize the frequent co-morbidities in migraine, and understand how these co-morbid factors contribute to our patient's disease burden.
2.00 CME credits
Medical Knowledge, Practice-based Learning and Improvement, Quality Improvement
Intermediate
Advanced Practice Provider
Resident, General Neurologist, Specialist Neurologist, Advanced Practice Provider
Didactic
Event Timeline
02:45 PM - 02:45 PM EST Speaker Introduction
Kenneth J. Mack, MD, PhD, FÂ鶹´«Ã½Ó³»­
02:45 PM - 03:25 PM EST Speaker Evaluation and Treatment of Pediatric Migraine
Hannah Shapiro, MD
03:25 PM - 04:05 PM EST Speaker Blocks, Botox, and Buzzers for Pediatric Headache
Christina L. Szperka, MD, FÂ鶹´«Ã½Ó³»­
04:05 PM - 04:45 PM EST Speaker Chronification and Co-Morbidities in Pediatric Headache
Kenneth J. Mack, MD, PhD, FÂ鶹´«Ã½Ó³»­
Faculty Disclosures
Kenneth J. Mack, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Mack has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Mack has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie. Dr. Mack has received publishing royalties from a publication relating to health care. Dr. Mack has received personal compensation in the range of $5,000-$9,999 for serving as a Expert Witness with Department of Justice, DVIC.
Christina L. Szperka, MD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Szperka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. The institution of Dr. Szperka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. The institution of Dr. Szperka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Szperka has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Szperka has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Upsher Smith. The institution of Dr. Szperka has received research support from PCORI. Dr. Szperka has a non-compensated relationship as a Cochair Scientific Committee with American Headache Society that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Hannah Shapiro, MD The institution of Dr. Shapiro has received research support from Pfizer. The institution of Dr. Shapiro has received research support from PCORI.